Acrivon Therapeutics, Inc. · NASDAQ:ACRV
Gamelin Erick had 404 Acrivon Therapeutics, Inc. shares withheld for tax (Form 4)
Traded May 14, 2026 · Filed May 18, 2026
On May 14, 2026, Gamelin Erick (Chief Development Officer) had 404 Acrivon Therapeutics, Inc. shares withheld for tax at US$1.92 for US$776, leaving 14,408 shares. Filed May 18, 2026 (Form 4).
- Withheld for tax
- 404 shares
- Price
- US$1.92
- Value
- US$776
- Holding after
- 14,408 shares
- Trading plan
- No
- Role
- Chief Development Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 14, 2026 | Common Stock | Shares withheld for tax | 404 | US$1.92 | 14,408 | Direct |
Source
Related
- Acrivon Therapeutics, Inc.
- Gamelin Erick
- Acrivon Therapeutics, Inc. shareholders
- Form 4 · Gamelin Erick · Aug 20, 2026
- Form 4 · Gamelin Erick · May 20, 2026
- Form 4 · Miller Mary · Oct 7, 2026
- Form 4 · Levin Michaela · Sep 2, 2026
- Form 4 · Blume-Jensen Peter · Aug 27, 2026
- Form 4 · Peterson Katharine · Aug 20, 2026
- Form 4 · Miller Mary · Aug 20, 2026